Evidence map›Paper›PMID 39779499›Full record

ReviewVirchows Archiv : an international journal of pathology2025

Germ cell tumors in children.

Peter Karl Bode, Luis Blasco-Santana, Isabel Colmenero, Miguel Reyes-Múgica

Abstract readReview
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peter Karl BodeDepartment of Pathology, Kantonsspital Winterthur, Winterthur, Switzerland. peter.bode@ksw.ch.ORCID http://orcid.org/0000-0002-9633-4042
Luis Blasco-SantanaDepartment of Histopathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Isabel ColmeneroDepartment of Histopathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Miguel Reyes-MúgicaDepartment of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID http://orcid.org/0000-0001-5698-3702

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pediatric germ cell tumors represent a rare but biologically diverse group of neoplasms arising from pluripotent primordial germ cells. The 2022 edition of the WHO Classification of Pediatric Tumors introduced the first organ independent classification of germ cell tumors, reflecting advances in molecular biology, histopathology, and clinical practice. This review highlights the key changes, including the refined distinctions between the different subtypes. These updates enhance diagnostic accuracy and provide a framework for understanding age-dependent differences in tumor biology and behavior. Emphasis is placed on integrating the new classification into multidisciplinary care, particularly in addressing diagnostic challenges in pre- and post-pubertal-type germ cell tumors. By bridging the gap between histopathology and oncology, the updated classification represents a pivotal step forward in improving outcomes for children with germ cell tumors.

Indexed as

Neoplasms, Germ Cell and EmbryonalChildChild, PreschoolHumansGerm cell tumorsGerminomaOCT3/4TeratomaWHO classification of pediatric tumorsYolk sac tumor

Identifiers

PMID39779499
PMCPMC11782398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.